Market Closed -
Other stock markets
|
5-day change | 1st Jan Change | ||
15.49 USD | +2.99% |
|
+2.04% | -7.85% |
06-05 | Catalyst Pharmaceuticals Insider Sold Shares Worth $276,735, According to a Recent SEC Filing | MT |
05-30 | Sector Update: Health Care Stocks Mixed Late Afternoon | MT |
This article is reserved for members
Already a member?
Log InNot a member ?
Free registration![Consensus](/images/consensus_flch.gif)
EPS Revisions
1st Jan change | Capi. | |
---|---|---|
-7.85% | 1.78B | |
+2.99% | 94.76B | |
-4.34% | 37.58B | |
-10.41% | 33.3B | |
+75.79% | 27.92B | |
-14.61% | 15.85B | |
-3.46% | 13.79B | |
-12.31% | 11.51B | |
+184.77% | 10.9B | |
-54.13% | 9.27B |
- Stock Market
- Equities
- CPRX Stock
- News Catalyst Pharmaceuticals, Inc.
- Santhera, Catalyst Pharmaceuticals Secure US FDA Nod for Rare Neuromuscular Disease Drug